The addition of neurodynamic therapy — a type of manual therapy targeting the nerves — to a standard treatment regimen…
Articles by Lindsey Shapiro, PhD
Pasithea Therapeutics announced plans to develop a tolerizing vaccine that would treat multiple sclerosis (MS) by…
Changes in the genome of oligodendrocytes were found in DNA regions associated with immune genes and risk mutations linked…
A relationship between meat consumption and how it affects gut bacteria, immune cell profiles, and metabolism was identified in people…
Adverse childhood experiences (ACEs) did not increase the risk of multiple sclerosis (MS) development and were not associated with…
Women with relapsing-remitting multiple sclerosis (RRMS) have more brain lesions and accelerated brain volume loss (BVL) after pregnancy compared…
A Kessler Foundation scientist has been awarded nearly $600,000 to support the development and testing of a behavioral…
Cyxone will work with a European organization to scale up production of the active ingredient in…
Among people with multiple sclerosis (MS), a progressive disease type and the use of anti-CD20 therapies — such as…
Following promising data from the first participant in a special access program that’s testing foralumab nasal spray for secondary progressive multiple…
Ocrevus (ocrelizumab) may be more effective than Gilenya (fingolimod) at preventing relapse in relapsing-remitting multiple sclerosis (RRMS)…